Full Press Release Details
GAITHERSBURG, Md., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company’s senior management team will participate in the following investor conferences during the fourth quarter and early portion of the first quarter of 2019:
JP Morgan – 2018 CEO Conference Call Series
Virtual/Conference Call (information to be provided by JP Morgan)
Three Part Advisors – 2018 Southwest IDEAS Investor Conference
November 14-15, 2018
Piper Jaffray – 30th Annual Healthcare Conference
November 27-29, 2018
Mizuho – Global Mizuho Investor Conference
BMO Capital Markets – 2018 Prescriptions for Success Healthcare Conference
JP Morgan – 37th Annual Healthcare Conference
Presentation dates and times will be updated on the Emergent website www.emergentbiosolutions.com under “Investors” as the information becomes available.
For these conferences, the company will be webcasting its presentation, which may include a discussion of the company's recent business developments as well as its most recently reported financial results and guidance. The webcasts will be available both live and by replay, accessible from the Emergent website.
About Emergent BioSolutions
Vice President, Investor Relations
Vice President, Corporate Communications